D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 66 Citations 14,400 119 World Ranking 1471 National Ranking 643

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Pathology
  • Gene

David W. Warnock focuses on Microbiology, Fluconazole, Amphotericin B, Itraconazole and Mycosis. His Fluconazole research is multidisciplinary, incorporating elements of Candida albicans, Corpus albicans and Internal medicine, Incidence. In his study, Immunology is strongly linked to Zygomycosis, which falls under the umbrella field of Corpus albicans.

His work carried out in the field of Internal medicine brings together such families of science as Surgery and Aspergillosis. His Amphotericin B study focuses on Flucytosine in particular. His Mycosis study combines topics in areas such as Infectious disease, Epidemiology and Intensive care medicine.

His most cited work include:

  • Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997 (594 citations)
  • Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program (587 citations)
  • Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 (519 citations)

What are the main themes of his work throughout his whole career to date?

David W. Warnock spends much of his time researching Microbiology, Itraconazole, Fluconazole, Amphotericin B and Aspergillosis. David W. Warnock combines subjects such as Pharmacology and Susceptibility testing with his study of Itraconazole. His Fluconazole research includes themes of Virology, Incidence, Mycosis and Drug resistance.

As part of one scientific family, David W. Warnock deals mainly with the area of Mycosis, narrowing it down to issues related to the Internal medicine, and often Surgery. His Amphotericin B research is multidisciplinary, relying on both Aspergillus flavus, Sporothrix schenckii, Coccidioides immitis and Etest. His Aspergillosis study integrates concerns from other disciplines, such as Hematopoietic stem cell transplantation, Intensive care medicine, Aspergillus and Paracoccidioidomycosis.

He most often published in these fields:

  • Microbiology (49.02%)
  • Itraconazole (21.57%)
  • Fluconazole (20.59%)

What were the highlights of his more recent work (between 2005-2017)?

  • Microbiology (49.02%)
  • Intensive care medicine (8.82%)
  • Cryptococcosis (7.84%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Microbiology, Intensive care medicine, Cryptococcosis, Immunology and Broth microdilution. The Microbiology study combines topics in areas such as Histoplasma, Yeast and Penicillium marneffei. He works mostly in the field of Cryptococcosis, limiting it down to concerns involving Aspergillosis and, occasionally, Chromoblastomycosis, Histoplasmosis and Candida albicans.

His research in Broth microdilution intersects with topics in Pharmacokinetics, Internal medicine, Voriconazole and Mycosis. His Internal medicine research incorporates elements of Medical mycology, Blood culture and Fluconazole. As a part of the same scientific study, David W. Warnock usually deals with the Mycosis, concentrating on Amphotericin B and frequently concerns with Corpus albicans.

Between 2005 and 2017, his most popular works were:

  • Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers (405 citations)
  • Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints (236 citations)
  • Manual of Clinical Microbiology, 11th Edition (175 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Pathology
  • Gene

Intensive care medicine, Epidemiology, Broth microdilution, Fungemia and Corpus albicans are his primary areas of study. His Intensive care medicine research incorporates themes from Infectious disease, Disease and Mortality rate. His Broth microdilution study results in a more complete grasp of Microbiology.

The study incorporates disciplines such as Pharmacokinetics, Pharmacodynamics and Phases of clinical research in addition to Microbiology. In his research on the topic of Corpus albicans, Aspergillosis is strongly related with Zygomycosis. David W. Warnock interconnects Fluconazole, Internal medicine, Blood culture and In vivo in the investigation of issues within Voriconazole.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997

Michael M. McNeil;Stephanie L. Nash;Rana A. Hajjeh;Maureen A. Phelan.
Clinical Infectious Diseases (2001)

864 Citations

Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

Rana A. Hajjeh;Andre N. Sofair;Lee H. Harrison;G. Marshall Lyon.
Journal of Clinical Microbiology (2004)

831 Citations

Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

Benito Almirante;Dolors Rodríguez;Benjamin J Park;Manuel Cuenca-Estrella.
Journal of Clinical Microbiology (2005)

822 Citations

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

John H. Rex;Michael A. Pfaller;Thomas J. Walsh;Vishnu Chaturvedi.
Clinical Microbiology Reviews (2001)

621 Citations

Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

Arnaldo L. Colombo;Marcio Nucci;Benjamin J. Park;Simone A. Nouér.
Journal of Clinical Microbiology (2006)

566 Citations

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

J. Morgan;K. A. Wannemuehler;K. A. Marr;S. Hadley.
Medical Mycology (2005)

518 Citations

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

M. A. Pfaller;D. J. Diekema;J. H. Rex;A. Espinel-Ingroff.
Journal of Clinical Microbiology (2006)

333 Citations

Manual of Clinical Microbiology, 11th Edition

Michael A. Pfaller;Sandra S. Richter;Guido Funke;James H. Jorgensen.
(2015)

330 Citations

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

Elizabeth M. Johnson;David W. Warnock;Jane Luker;Stephen R. Porter.
Journal of Antimicrobial Chemotherapy (1995)

327 Citations

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.

E M Johnson;A Szekely;D W Warnock.
Journal of Antimicrobial Chemotherapy (1998)

287 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David W. Warnock

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 103

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 92

David W. Denning

David W. Denning

University of Manchester

Publications: 86

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 84

Daniel J. Diekema

Daniel J. Diekema

University of Iowa Hospitals and Clinics

Publications: 83

Arnaldo Lopes Colombo

Arnaldo Lopes Colombo

Federal University of Sao Paulo

Publications: 72

Shawn A. Messer

Shawn A. Messer

JMI Laboratories

Publications: 63

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 56

Kieren A. Marr

Kieren A. Marr

Johns Hopkins University School of Medicine

Publications: 56

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 54

Juan L. Rodriguez-Tudela

Juan L. Rodriguez-Tudela

Global Action for Fungal Infections (GAFFI)

Publications: 48

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 47

Guillermo Quindós

Guillermo Quindós

University of the Basque Country

Publications: 46

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 45

Tania C. Sorrell

Tania C. Sorrell

University of Sydney

Publications: 43

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 43

Trending Scientists

Guilherme Horta Travassos

Guilherme Horta Travassos

Federal University of Rio de Janeiro

Christos Volos

Christos Volos

Aristotle University of Thessaloniki

Doo-Yeol Yoo

Doo-Yeol Yoo

Hanyang University

André Laschewsky

André Laschewsky

University of Potsdam

Russell L. Rouseff

Russell L. Rouseff

Southwest University

J. M. Hartmann

J. M. Hartmann

CEA LETI

Jennifer U. M. Jarvis

Jennifer U. M. Jarvis

University of Cape Town

David E. Johnson

David E. Johnson

International Rice Research Institute

Fabrice Gouilleux

Fabrice Gouilleux

François Rabelais University

Takashi Nonaka

Takashi Nonaka

Tokyo Metropolitan Institute of Medical Science

Kostas Pantopoulos

Kostas Pantopoulos

McGill University

David Valle

David Valle

Johns Hopkins University School of Medicine

Bridget T. Hill

Bridget T. Hill

The Honourable Society of Lincoln's Inn

Wilhelm H. Holzapfel

Wilhelm H. Holzapfel

Handong Global University

James M. Ford

James M. Ford

Stanford University

Steven P. Wallace

Steven P. Wallace

University of California, Los Angeles

Something went wrong. Please try again later.